The Valley Desk

NCT02705313 · Expanded access

EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx

Overall registry status Approved for marketing

Conditions Neuroendocrine Tumors

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov